New Chiefs Named for the Division of Rheumatology, Inflammation an Immunity, Division of Allergy and Clinical Immunology
On Oct. 1, the Division of Rheumatology, Immunology and Allergy within the Department of Medicine will be split into two separate and distinct divisions: The Division of Rheumatology, Inflammation and Immunity and the Division of Allergy and Clinical Immunology. Ellen M. Gravallese, MD, has been named chief of the Division of Rheumatology, Inflammation and Immunity. Joshua A. Boyce, MD, has been named chief of the Division of Allergy and Clinical Immunology. They succeed Michael Brenner, MD, who led the former Division of Rheumatology, Immunology and Allergy. Each will become chief of the newly-constituted divisions in October.
This marks a return to Brigham Health for Gravallese. After earning her MD from the Columbia University College of Physicians and Surgeons, she completed a joint residency program in both internal medicine and pathology, followed by a fellowship in rheumatology at the Brigham. She then undertook a postdoctoral research fellowship in immunology at Harvard in the laboratory of Laurie Glimcher, MD. She served on the faculty at the Brigham from 1991 until 1998 before moving to Beth Israel Deaconess Medical Center from 1999 to 2006, where she conducted basic and translational research at the Harvard Institutes of Medicine. In 2006, Gravallese was recruited to be chief of the Division of Rheumatology at the University of Massachusetts (UMass) Memorial Medical Center and professor of Medicine at UMass Medical School. Since 2011, she has served as director for Translational Research for the Musculoskeletal Center of Excellence at UMass Memorial Medical Center. She received tenure in 2012 and in 2013 was appointed the Myles J. McDonough Chair in Rheumatology at UMass Medical School.
Gravallese has a distinguished record of accomplishments as a scientist, educator and clinician. Her research on fundamental mechanisms of inflammation and joint destruction in inflammatory disease has changed the scientific understanding and focus of treatment for rheumatoid arthritis, furthered the development of a new area of scientific investigation termed “osteoimmunology” and imparted key insights into the contribution of innate immune mechanisms to systemic autoimmune diseases. Gravallese has also been the recipient of major awards, including the Sandoz Award for medical research, the Steven M. Krane Award from the American Society for Bone and Mineral Research and the international Carol Nachman Prize for research in Rheumatology. She serves as associate editor at New England Journal of Medicine, and, beginning in November, she will serve as president of the American College of Rheumatology.
Boyce is the Albert L. Sheffer Professor of Medicine in the Field of Allergic Disease at Harvard Medical School. He has served as associate division chief since 2015 and as director of the Inflammation and Allergic Disease Research Section since 2010.
Boyce has a distinguished record of accomplishments as a scientist, clinician, and educator, and his leadership will integrate all these key activities of the division. He is an active investigator who has performed seminal research on how lipid mediators and their receptors function as a network to control the development and activation of mast cells, a central cell type in the effector phase of all allergic diseases. He has helped oversee the growth of the allergy clinical service into one of the largest academic practices in the Northeast. Boyce has been the recipient of a range of major awards, including a National Institute of Allergy and Infectious Diseases MERIT Award. He currently serves as associate editor of the Journal of Allergy and Clinical Immunology.
Resnick Appointed Senior Vice President, Chief Quality Officer
Andrew Resnick, MD, MBA, has been appointed senior vice president, chief quality officer. Resnick, who currently serves as chief medical officer (CMO) of Froedtert Hospital (FH), associate dean of Clinical Affairs Adult Practice and associate professor, General Surgery at The Medical College of Wisconsin (MCW), will join Brigham Health on Oct. 28 as the newest member of the Office of the Chief Medical Officer.
Resnick’s devotion to quality, safety and exceptional patient care, combined with his extensive physician leadership experience and operational expertise, make him an excellent fit for this vitally important role. Resnick’s central motivation is to transform health care, creating a patient-centered care delivery system that is high quality and cost effective for hospitals, providers, payers and patients, and provides a patient-focused experience for its customers. As CMO and associate dean at FH and MCW, Resnick has oversight of clinical performance as well as clinical operations, and has helped drive improvements in quality, efficiency, cost, access, staff engagement and patient experience across the 614-bed acute care hospital and a multi-specialty group with more than 1,350 physicians, 500 advanced practice providers and other practitioners.
Resnick was previously at Penn State Milton S. Hershey Medical Center where he served as chief quality officer. There, he had a profound impact on quality and safety. He led development of interprofessional, unit-based quality teams to empower frontline staff, as well as clinical and operational leaders to impact patient care quality and safety at the local level. Andrew started his professional career at the University of Pennsylvania, where he oversaw many quality improvement activities across the organization, and ultimately served as the chief surgical quality officer. Andrew graduated from Dartmouth College and Yale University School of Medicine. He completed a surgical residency at the Hospital of the University of Pennsylvania and earned an MBA at The Wharton School.
Carney Named Senior Vice President for Real Estate, Facilities, and Operations
Douglas “Doug” Carney, MBA, has been appointed the senior vice president of Real Estate, Facilities, and Operations. Carney, who currently serves as senior vice president of the Facilities, Real Estate and Capital Program at Children’s Hospital of Philadelphia (CHoP), will join Brigham Health on Oct. 15.
Carney’s extensive leadership experience and track record of overseeing major capital projects and complex facilities initiatives, at significant scale within a premiere academic medical system, made him both the clear choice among the diverse set of candidates and the perfect fit for our institution.
While at CHoP, Carney collaborated with senior leadership and the board in successfully planning and leading an extensive expansion of the hospital’s main campus and its network. At CHoP, he is responsible for an annual capital budget of $275 million and operating budget of more than $150 million, and previously served as a non-voting member of the Finance and Capital Program Committee and Buildings and Grounds Sub-committee of the CHoP Board of Trustees. This experience will be invaluable as Brigham Health continues to plan for and evolve our campus and operations over the next decade.
Carney has practiced as an architect for over 35 years, both in private practice and as a partner at Sustainable Program Management, a firm focused on real estate, design and construction for the public sector. For more than three decades, he has gained extensive experience with contract management, site analysis, master planning, feasibility and zoning studies, space needs, program development, code analysis and compliance studies, and project scheduling.
Earlier in his career, Carney served in facilities and real estate leadership roles in the Jefferson Health System and at the University of Pennsylvania. He graduated from Carnegie Mellon University and earned a master’s in business administration from Eastern University.
Sato Joins Brigham Digital Innovation Hub
Rintaro (Rin) Sato has been appointed an innovation and operations analyst at Brigham Digital Innovation Hub (iHub). He began in the role at the end of August.
Sato has international work experience supporting innovative projects for a variety of clients ranging from startups in Tokyo to a U.S. state government agency. His interest in connecting people with technology began while studying information systems and international relations and politics at Carnegie Mellon University. After graduating, he started his career at Deloitte Consulting as a business technology analyst to support project management for a U.S. State Department of Human Services. During his time at Deloitte, he also assisted Deloitte Japan’s Tohmatsu Venture Support (TVS) to connect TVS with startup communities on the East Coast. He decided to dive deeper into Japan’s startup ecosystem by joining an artificial intelligence consulting and development startup where he worked as a project manager prior to joining iHub.
Nivetha Paterson has been appointed senior director of Patient and Family Relations, effective immediately. She has made significant contributions while serving in the role on an interim basis over the last few months.